SEC Form 4 · accession 0001209191-15-037394

LEMAITRE VASCULAR INC · LMAT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President, International OP

Period of report

Apr 28, 2015

Accepted (ET)

Apr 30, 2015 · 4:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001158895

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Apr 28, 2015	M	832	$0.102	A	42,139	D
Common Stock^F2	Apr 28, 2015	S	832	$8.90	D	41,307	D
Common Stock^F1	Apr 29, 2015	M	14,500	$0.102	A	55,807	D
Common Stock^F2,F3	Apr 29, 2015	S	14,500	$8.9932	D	41,307	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4,F5	$0.102	Apr 28, 2015	M	832	D	Jun 2, 1997	Jun 2, 2007	Common Stock	832	151,357	D
Stock Option (Right to Buy)^F4,F5	$0.102	Apr 29, 2015	M	14,500	D	Jun 2, 1997	Jun 2, 2007	Common Stock	14,500	136,857	D

F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F3The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $8.90 to $9.16. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F4This option is fully vested and exercisable.
F5This stock option was originally reported on Form 3 as having an expiration date of June 2, 2007, but does not in fact have an expiration date. Because an expiration date is required to be reported, the originally reported expiration date is included for the sake of consistency.